{
  "id": "7f9e3ee7ecd121db",
  "title": "Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations",
  "description": "AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) \u2014 BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimat\u2026",
  "content": "Soligenix is focused on several initiatives that fit within these national healthcare objectives. The company recently shifted U.S.-based manufacturing of HyBrytes active pharmaceutical ingredient, s\u2026 [+3933 chars]",
  "source": "Financial Post",
  "source_url": "https://financialpost.com/globe-newswire/breakthrough-therapies-advance-as-rare-disease-burden-intensifies-across-aging-populations",
  "published_at": "2025-12-04T13:31:49Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "demographics_migration",
  "subcategory": null,
  "keywords": [
    "healthcare",
    "aging",
    "search:regulatory agency action"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": "financial-post",
      "name": "Financial Post"
    },
    "author": "GlobeNewswire",
    "title": "Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations",
    "description": "AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) \u2014 BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimat\u2026",
    "url": "https://financialpost.com/globe-newswire/breakthrough-therapies-advance-as-rare-disease-burden-intensifies-across-aging-populations",
    "urlToImage": null,
    "publishedAt": "2025-12-04T13:31:49Z",
    "content": "Soligenix is focused on several initiatives that fit within these national healthcare objectives. The company recently shifted U.S.-based manufacturing of HyBrytes active pharmaceutical ingredient, s\u2026 [+3933 chars]"
  }
}